Preface |
|
xix | |
Acknowledgments |
|
xxi | |
|
|
1 | (8) |
|
The Effect of the Body on the Chemical |
|
|
1 | (1) |
|
|
1 | (1) |
|
|
1 | (1) |
|
|
2 | (1) |
|
|
2 | (1) |
|
|
2 | (1) |
|
|
3 | (1) |
|
|
3 | (1) |
|
|
4 | (1) |
|
Enzyme Location in Toxicity |
|
|
4 | (1) |
|
|
5 | (1) |
|
|
5 | (1) |
|
|
5 | (1) |
|
|
6 | (1) |
|
Interaction of Chemical and the Body |
|
|
6 | (1) |
|
Enzyme Induction and Inhibition |
|
|
6 | (1) |
|
Activation, Induction, or Synergism |
|
|
6 | (1) |
|
|
6 | (1) |
|
Dose Dependency and Site of Action |
|
|
7 | (1) |
|
Organ Specificity for Toxicity |
|
|
7 | (1) |
|
Site-Specific Interactions and Toxicity |
|
|
7 | (1) |
|
|
7 | (1) |
|
Direct and Cascade Effects |
|
|
7 | (1) |
|
Nonspecific Interations and Toxicity |
|
|
7 | (1) |
|
Electrophiles and Covalent Binding |
|
|
7 | (1) |
|
|
8 | (1) |
|
Manifestations of Toxic Cell Injury: Cell Injury/Death and Chemical Carcinogenesis |
|
|
9 | (34) |
|
Cell Injury, Cell Death and Sequelae |
|
|
10 | (1) |
|
|
10 | (3) |
|
Key Cellular Components in Cell Injury |
|
|
10 | (1) |
|
Factors Influencing Injury |
|
|
10 | (1) |
|
Reaction of the Body to Injury |
|
|
11 | (1) |
|
|
11 | (2) |
|
|
13 | (2) |
|
|
13 | (1) |
|
|
14 | (1) |
|
|
15 | (8) |
|
|
15 | (4) |
|
|
19 | (2) |
|
Sequelae to Irreversible Cell Injury |
|
|
21 | (2) |
|
|
23 | (1) |
|
|
23 | (1) |
|
|
23 | (1) |
|
Nomenclature of Neoplasms |
|
|
24 | (1) |
|
Spectrum of Proliferative Lesions |
|
|
25 | (3) |
|
Quantitative Cell Proliferation (Hyperplasia) |
|
|
25 | (1) |
|
Qualitative Cell Proliferation |
|
|
26 | (1) |
|
|
27 | (1) |
|
Neoplastic Cell Proliferation |
|
|
27 | (1) |
|
Diagnostic Distinction between Preneoplasia, Benign Neoplasia, and Malignant Neoplasia |
|
|
28 | (1) |
|
Steps in the Neoplastic Process |
|
|
28 | (2) |
|
|
28 | (1) |
|
|
29 | (1) |
|
|
29 | (1) |
|
Hypotheses of Mode of Action of Chemical Carcinogens |
|
|
30 | (3) |
|
|
30 | (1) |
|
Mutational Genetic Hypothesis of Chemical Carcinogenesis |
|
|
30 | (1) |
|
Nonmutational Genetic Hypothesis of Chemical Carcinogenesis |
|
|
31 | (1) |
|
Epigenetic Hypothesis of Chemical Carcinogenesis |
|
|
31 | (1) |
|
Viral Hypothesis of Carcinogenesis |
|
|
32 | (1) |
|
Oncogenes and Tumor Suppressor Genes in Chemical Carcinogenesis |
|
|
33 | (3) |
|
|
33 | (1) |
|
|
33 | (1) |
|
Proto-oncogene Activation |
|
|
33 | (1) |
|
Oncogene Activation in Chemical Carcinogenesis |
|
|
34 | (2) |
|
Tumor Suppressor Genes and Carcinogenesis |
|
|
36 | (1) |
|
Cell Cycle and Carcinogenesis |
|
|
36 | (1) |
|
|
36 | (1) |
|
Retinoblastoma Checkpoint |
|
|
36 | (1) |
|
|
37 | (1) |
|
Tests for Carcinogenic Potential of Chemicals |
|
|
37 | (4) |
|
In Vivo Chronic Rodent Carcinogenesis Studies |
|
|
37 | (2) |
|
Additional In Vivo Tests for Carcinogenicity |
|
|
39 | (2) |
|
In Vitro Short-term Tests |
|
|
41 | (1) |
|
|
41 | (1) |
|
|
41 | (2) |
|
|
43 | (24) |
|
|
43 | (1) |
|
|
44 | (6) |
|
Parameters Generally Included in Study Protocols |
|
|
44 | (1) |
|
Interpretative Hematology |
|
|
45 | (5) |
|
|
50 | (7) |
|
Cholesterol, Triglycerides, and Glucose |
|
|
50 | (3) |
|
|
53 | (1) |
|
Indicators of Hepatic Integrity and Function |
|
|
54 | (2) |
|
Indicators of Renal Function |
|
|
56 | (1) |
|
|
56 | (1) |
|
Calcium and Inorganic Phosphate |
|
|
57 | (1) |
|
|
57 | (1) |
|
Microsomal Enzyme Induction |
|
|
57 | (1) |
|
|
58 | (1) |
|
Interpretation of Clinical Pathology Results |
|
|
59 | (5) |
|
Potential Effects of Factors Unrelated to Test Article Treatment |
|
|
60 | (1) |
|
Comparators: Concurrent Controls, Reference Ranges |
|
|
61 | (1) |
|
|
62 | (1) |
|
Direct Versus Indirect Effects |
|
|
62 | (1) |
|
Pharmacologic Versus Toxic Effects |
|
|
63 | (1) |
|
Biological Importance of Treatment-related Effects |
|
|
63 | (1) |
|
Reporting of Clinical Pathology Findings |
|
|
64 | (1) |
|
|
64 | (1) |
|
|
64 | (3) |
|
Nomenclature: Terminology for Morphologic Alterations |
|
|
67 | (14) |
|
|
67 | (1) |
|
|
68 | (1) |
|
|
68 | (9) |
|
|
73 | (1) |
|
|
74 | (1) |
|
|
75 | (1) |
|
|
75 | (1) |
|
Standardized Nomenclature |
|
|
76 | (1) |
|
|
76 | (1) |
|
|
77 | (1) |
|
|
78 | (1) |
|
|
79 | (2) |
|
Techniques in Toxicologic Pathology |
|
|
81 | (12) |
|
|
81 | (1) |
|
Factors Influencing Evaluation of Altered Morphology |
|
|
82 | (9) |
|
Factors in Collection and Processing of Tissue |
|
|
84 | (3) |
|
Factors Intrinsic to the Animal |
|
|
87 | (3) |
|
Factors Related to the Environment |
|
|
90 | (1) |
|
Factors Related to Nomenclature |
|
|
91 | (1) |
|
|
91 | (2) |
|
|
93 | (42) |
|
|
93 | (1) |
|
Structure and Cell Biology |
|
|
94 | (10) |
|
Macroscopic and Microscopic Anatomy |
|
|
94 | (6) |
|
Physiology and Functional Considerations |
|
|
100 | (2) |
|
Xenobiotic Exposure, Metabolism, and Excretion |
|
|
102 | (2) |
|
|
104 | (5) |
|
|
105 | (1) |
|
|
105 | (1) |
|
|
106 | (2) |
|
Toxicity and Responses to Inhaled Particles |
|
|
108 | (1) |
|
|
109 | (1) |
|
Modifying Factors in Toxicity |
|
|
109 | (1) |
|
|
109 | (19) |
|
Injury, Regeneration, and Repair |
|
|
110 | (1) |
|
Nasopharyngeal and Laryngeal Responses to Injury |
|
|
111 | (2) |
|
Airway Response to Injury |
|
|
113 | (5) |
|
Pulmonary Parenchymal Response to Injury |
|
|
118 | (1) |
|
|
119 | (2) |
|
|
121 | (3) |
|
|
124 | (2) |
|
|
126 | (1) |
|
|
127 | (1) |
|
|
128 | (5) |
|
|
129 | (1) |
|
|
130 | (1) |
|
|
130 | (1) |
|
|
131 | (1) |
|
|
131 | (2) |
|
|
133 | (1) |
|
|
133 | (2) |
|
|
135 | (28) |
|
|
135 | (6) |
|
|
135 | (1) |
|
Structure and Function of Skin |
|
|
136 | (1) |
|
|
136 | (2) |
|
|
138 | (1) |
|
Physiology and Biochemistry |
|
|
138 | (3) |
|
Comparative Mechanisms of Cutaneous Toxicity |
|
|
141 | (6) |
|
|
141 | (3) |
|
Immunomediated Cutaneous Toxicity |
|
|
144 | (2) |
|
Phototoxicity and Photoallergy |
|
|
146 | (1) |
|
Response of Skin to Injury |
|
|
147 | (9) |
|
Fundamental Non-neoplastic Lesions |
|
|
147 | (8) |
|
|
155 | (1) |
|
Evaluation of Cutaneous Toxicity |
|
|
156 | (3) |
|
|
157 | (1) |
|
|
157 | (1) |
|
|
158 | (1) |
|
|
158 | (1) |
|
|
158 | (1) |
|
|
159 | (1) |
|
|
159 | (2) |
|
|
159 | (1) |
|
Structure and Function of the Oral Mucosa |
|
|
159 | (1) |
|
|
159 | (1) |
|
|
159 | (1) |
|
Comparative Mechanisms of Mucosal Toxicity |
|
|
160 | (1) |
|
Response of Oral Mucosa to Injury |
|
|
160 | (1) |
|
Fundamental Non-neoplastic Lesions |
|
|
160 | (1) |
|
|
161 | (1) |
|
Evaluation of Oral Toxicity |
|
|
161 | (1) |
|
|
161 | (2) |
|
|
163 | (34) |
|
|
163 | (1) |
|
Structure and Function of the Gastrointestinal Tract |
|
|
164 | (11) |
|
Macroscopic and Microscopic Structure and Function |
|
|
164 | (7) |
|
|
171 | (1) |
|
|
172 | (1) |
|
|
172 | (2) |
|
|
174 | (1) |
|
Enterohepatic Circulation |
|
|
174 | (1) |
|
Comparative Mechanisms of Gastrointestinal Toxicity |
|
|
175 | (9) |
|
Intestinal Barrier Function |
|
|
175 | (2) |
|
|
177 | (1) |
|
|
177 | (1) |
|
Mucosal Barrier Damage and Cytotoxicity |
|
|
178 | (3) |
|
|
181 | (2) |
|
|
183 | (1) |
|
Perturbation of Microflora |
|
|
183 | (1) |
|
|
183 | (1) |
|
Response of the Gastrointestinal Tract to Injury |
|
|
184 | (7) |
|
Pathophysiological Responses |
|
|
184 | (2) |
|
|
186 | (1) |
|
|
187 | (2) |
|
|
189 | (2) |
|
Evaluation of Gastrointestinal Toxicity |
|
|
191 | (5) |
|
|
191 | (1) |
|
|
192 | (1) |
|
|
192 | (1) |
|
|
193 | (1) |
|
|
194 | (2) |
|
|
196 | (1) |
|
|
197 | (40) |
|
|
197 | (1) |
|
|
197 | (3) |
|
Gross and Microscopic Anatomy |
|
|
198 | (1) |
|
|
198 | (2) |
|
|
200 | (1) |
|
|
200 | (2) |
|
Classification of Hepatoxicants |
|
|
201 | (1) |
|
Cellular Mechanisms of Toxicity |
|
|
201 | (1) |
|
Non-neoplastic Responses to Injury |
|
|
202 | (26) |
|
Histologic Types of Hepatic Necrosis |
|
|
208 | (6) |
|
Intracellular Accumulations |
|
|
214 | (4) |
|
Pathology of Transcription and Translation |
|
|
218 | (1) |
|
|
219 | (1) |
|
Hepatocellular Adaptive Responses |
|
|
219 | (1) |
|
Hepatocellular Proliferation |
|
|
220 | (1) |
|
|
221 | (3) |
|
Nonparenchymal Cell Toxicity |
|
|
224 | (1) |
|
|
225 | (1) |
|
Hepatic Fibrosis and Cirrhosis |
|
|
226 | (2) |
|
|
228 | (1) |
|
|
228 | (3) |
|
|
230 | (1) |
|
|
231 | (1) |
|
|
231 | (1) |
|
|
231 | (4) |
|
|
232 | (1) |
|
Clinical Chemistry Evaluation |
|
|
232 | (2) |
|
|
234 | (1) |
|
|
234 | (1) |
|
|
234 | (1) |
|
|
235 | (1) |
|
|
235 | (2) |
|
|
237 | (24) |
|
|
237 | (1) |
|
|
237 | (1) |
|
Normal Structure of Exocrine Pancreas |
|
|
238 | (2) |
|
|
238 | (1) |
|
Microscopic Anatomy and Ultrastructure |
|
|
238 | (2) |
|
Physiology of Exocrine Pancreas |
|
|
240 | (1) |
|
Comparative Mechanisms of Exocrine Pancreatic Toxicity |
|
|
241 | (2) |
|
Response of Exocrine Pancreas to Injury |
|
|
243 | (5) |
|
Cytotoxic Effects on Acinar Cells |
|
|
243 | (4) |
|
Cytotoxic Effects in Ductal and Centroacinar Cells |
|
|
247 | (1) |
|
|
247 | (1) |
|
Evaluation of Exocrine Pancreatic Toxicity |
|
|
248 | (2) |
|
|
249 | (1) |
|
Morphologic Evaluation of Toxicity |
|
|
250 | (1) |
|
|
250 | (1) |
|
|
250 | (1) |
|
|
251 | (1) |
|
Structure of Endocrine Pancreas |
|
|
251 | (1) |
|
|
251 | (1) |
|
Microscopic Anatomy and Ultrastructure |
|
|
251 | (1) |
|
Physiology of Endocrine Pancreas |
|
|
252 | (1) |
|
Mechanisms of Endocrine Pancreatic Toxicity |
|
|
253 | (3) |
|
Insulin-dependent Diabetes Mellitus |
|
|
253 | (1) |
|
Non-insulin-dependent Diabetes Mellitus |
|
|
254 | (1) |
|
|
255 | (1) |
|
Response of Endocrine Pancreas to Injury |
|
|
256 | (2) |
|
|
256 | (1) |
|
|
256 | (1) |
|
|
257 | (1) |
|
|
258 | (1) |
|
|
258 | (1) |
|
Evaluation of Endocrine Pancreatic Toxicity |
|
|
258 | (1) |
|
|
258 | (1) |
|
|
258 | (1) |
|
|
258 | (1) |
|
|
258 | (1) |
|
|
259 | (2) |
|
Kidney and Lower Urinary Tract |
|
|
261 | (58) |
|
|
261 | (1) |
|
Renal Structure and Function |
|
|
262 | (11) |
|
Gross, Microscopic, and Ultrastructural Anatomy |
|
|
262 | (7) |
|
|
269 | (4) |
|
|
273 | (30) |
|
Overview and Classification |
|
|
273 | (2) |
|
|
275 | (9) |
|
|
284 | (12) |
|
Other Sites of Renal Injury |
|
|
296 | (3) |
|
|
299 | (1) |
|
|
300 | (3) |
|
Lower Urinary Tract Carcinogenesis |
|
|
303 | (1) |
|
|
303 | (11) |
|
|
303 | (1) |
|
|
303 | (1) |
|
Proximal Tubule and Interstitium |
|
|
304 | (5) |
|
|
309 | (1) |
|
Renal Tubular Hyperplasia and Neoplasia |
|
|
309 | (1) |
|
Lower Urinary Tract: Non-neoplastic Lesions |
|
|
310 | (3) |
|
Lower Urinary Tract Epithelial Neoplasms |
|
|
313 | (1) |
|
|
314 | (3) |
|
Diagnostic Evaluation of Renal Disease |
|
|
314 | (1) |
|
Routine Screening for Nephrotoxicity |
|
|
314 | (1) |
|
|
315 | (1) |
|
Evaluation of the Lower Urinary Tract |
|
|
316 | (1) |
|
|
317 | (1) |
|
|
317 | (2) |
|
Cardiovascular and Skeletal Muscle Systems |
|
|
319 | (58) |
|
|
320 | (1) |
|
|
320 | (1) |
|
|
320 | (4) |
|
Gross and Microscopic Anatomy |
|
|
320 | (1) |
|
Cellular and Extracellular Elements of the Heart: Biology and Clinical Relevance |
|
|
321 | (2) |
|
Physiology and Functional Considerations |
|
|
323 | (1) |
|
|
324 | (1) |
|
|
324 | (7) |
|
Physiological Mechanisms of Functional Alterations |
|
|
324 | (4) |
|
Biochemical Mechanisms of Cardiotoxicosis |
|
|
328 | (1) |
|
Cardiotoxicoses Due to Direct Cellular Injury |
|
|
329 | (1) |
|
Cardiotoxicoses Due to Indirect Acting Injury |
|
|
329 | (1) |
|
Organellar Localization of Injury |
|
|
330 | (1) |
|
|
331 | (1) |
|
|
331 | (15) |
|
Developmental Cardiotoxicities |
|
|
334 | (1) |
|
|
335 | (11) |
|
|
346 | (1) |
|
|
346 | (1) |
|
|
346 | (1) |
|
Evaluation of Cardiotoxicity |
|
|
346 | (5) |
|
Physiologic Evaluation of Toxicity |
|
|
347 | (2) |
|
Morphologic Evaluation of Toxicity |
|
|
349 | (2) |
|
Biochemical Evaluation of Toxicity |
|
|
351 | (1) |
|
|
351 | (1) |
|
|
351 | (1) |
|
|
351 | (1) |
|
|
352 | (3) |
|
|
352 | (1) |
|
Physiology and Functional Considerations |
|
|
352 | (3) |
|
|
355 | (2) |
|
Vasculotoxic Effects of Xenobiotics |
|
|
355 | (1) |
|
Vascular Toxicity in Specific Organs |
|
|
356 | (1) |
|
|
357 | (6) |
|
|
358 | (1) |
|
|
358 | (5) |
|
Evaluation of Vasotoxic Effects |
|
|
363 | (2) |
|
Physiologic Methods for Testing |
|
|
363 | (1) |
|
|
364 | (1) |
|
|
364 | (1) |
|
|
365 | (1) |
|
|
365 | (1) |
|
|
365 | (2) |
|
Gross and Microscopic Anatomy |
|
|
365 | (1) |
|
Cells of Skeletal Muscle: Biology and Clinical Relevance |
|
|
365 | (2) |
|
Physiologic and Functional Considerations |
|
|
367 | (1) |
|
|
367 | (3) |
|
Altered Neurogenic Function |
|
|
367 | (1) |
|
Altered Immunologic Function |
|
|
368 | (1) |
|
|
368 | (1) |
|
Cell Membrane Alterations |
|
|
368 | (1) |
|
Sarcoplasmic Reticulum Alterations |
|
|
369 | (1) |
|
|
369 | (1) |
|
|
369 | (1) |
|
|
369 | (1) |
|
Altered Intracellular Calcium Concentration |
|
|
369 | (1) |
|
Altered Protein Synthesis |
|
|
369 | (1) |
|
Altered Muscle Cell Differentiation |
|
|
370 | (1) |
|
|
370 | (3) |
|
Injury, Regeneration, and Repair |
|
|
370 | (1) |
|
Skeletal Muscle Alterations |
|
|
371 | (2) |
|
Evaluation of Skeletal Muscle Toxicity |
|
|
373 | (3) |
|
|
374 | (1) |
|
|
374 | (2) |
|
|
376 | (1) |
|
|
376 | (1) |
|
|
377 | (34) |
|
|
377 | (1) |
|
|
378 | (9) |
|
|
378 | (1) |
|
|
379 | (2) |
|
Specialized Anatomical Features |
|
|
381 | (1) |
|
Select Functions and Neurotoxicity |
|
|
382 | (5) |
|
Mechanisms of Disease and Classification of Neurotoxic Diseases |
|
|
387 | (18) |
|
|
387 | (9) |
|
|
396 | (2) |
|
|
398 | (2) |
|
Toxicants Affecting Vascular Integrity |
|
|
400 | (4) |
|
Developmental Neurotoxicants |
|
|
404 | (1) |
|
|
405 | (1) |
|
Evaluation of Neurotoxicity |
|
|
405 | (4) |
|
|
405 | (1) |
|
Tests of Nervous System Function |
|
|
405 | (1) |
|
|
406 | (3) |
|
|
409 | (1) |
|
|
409 | (1) |
|
|
410 | (1) |
|
|
411 | (40) |
|
|
411 | (1) |
|
Skeletal Structure and Composition |
|
|
412 | (5) |
|
Formation and Development |
|
|
412 | (4) |
|
|
416 | (1) |
|
Species Differences in Composition and Changes with Age |
|
|
416 | (1) |
|
Bone Physiology and Function |
|
|
417 | (3) |
|
Modeling and Remodeling of Bone |
|
|
417 | (1) |
|
|
417 | (1) |
|
|
418 | (1) |
|
Regulation of Bone Cell Function |
|
|
418 | (2) |
|
|
420 | (8) |
|
|
420 | (6) |
|
|
426 | (2) |
|
Response of the Skeleton to Toxic Injury |
|
|
428 | (14) |
|
|
428 | (10) |
|
|
438 | (4) |
|
Evaluation of Skeletal Toxicity |
|
|
442 | (6) |
|
Testing for Skeletal Toxicity |
|
|
442 | (1) |
|
|
443 | (4) |
|
|
447 | (1) |
|
Animal Models of Skeletal Disease |
|
|
448 | (1) |
|
|
448 | (1) |
|
|
449 | (2) |
|
|
451 | (40) |
|
|
451 | (1) |
|
Function and Structure of the Immune System |
|
|
451 | (16) |
|
Function of the Immune System |
|
|
451 | (5) |
|
Structure of the Immune System |
|
|
456 | (11) |
|
Comparative Mechanisms of Immune Toxicity |
|
|
467 | (10) |
|
|
467 | (1) |
|
Examples of Immunotoxic Agents |
|
|
468 | (9) |
|
Response of the Immune System to Toxic Injury |
|
|
477 | (9) |
|
|
478 | (6) |
|
|
484 | (1) |
|
|
484 | (1) |
|
Inflammation in Nonlymphoid Tissues |
|
|
485 | (1) |
|
Testing for Immunotoxicity |
|
|
486 | (3) |
|
In Vivo and In Vitro Approaches |
|
|
486 | (1) |
|
|
487 | (1) |
|
|
488 | (1) |
|
|
489 | (1) |
|
|
489 | (2) |
|
|
491 | (22) |
|
|
491 | (1) |
|
|
491 | (1) |
|
|
492 | (1) |
|
|
492 | (4) |
|
Gross and Microscopic Anatomy |
|
|
492 | (2) |
|
|
494 | (1) |
|
|
495 | (1) |
|
Comparative Mechanisms of Toxicity |
|
|
496 | (7) |
|
|
496 | (3) |
|
|
499 | (2) |
|
|
501 | (2) |
|
Responses of Hematopoietic Tissues to Toxic Injury |
|
|
503 | (7) |
|
|
503 | (2) |
|
|
505 | (5) |
|
|
510 | (2) |
|
|
512 | (1) |
|
|
512 | (1) |
|
|
513 | (40) |
|
|
513 | (1) |
|
|
513 | (10) |
|
|
513 | (3) |
|
|
516 | (1) |
|
|
516 | (7) |
|
|
523 | (1) |
|
|
523 | (2) |
|
|
523 | (1) |
|
|
523 | (1) |
|
|
523 | (2) |
|
|
525 | (1) |
|
|
525 | (5) |
|
|
525 | (2) |
|
|
527 | (1) |
|
|
527 | (3) |
|
|
530 | (1) |
|
|
530 | (2) |
|
|
530 | (1) |
|
|
531 | (1) |
|
|
531 | (1) |
|
|
532 | (11) |
|
|
532 | (4) |
|
|
536 | (2) |
|
|
538 | (5) |
|
|
543 | (1) |
|
|
543 | (7) |
|
|
543 | (1) |
|
|
544 | (2) |
|
|
546 | (1) |
|
Response of Parathyroid Chief Cells to Injury |
|
|
547 | (3) |
|
|
550 | (1) |
|
|
550 | (3) |
|
|
553 | (46) |
|
|
553 | (1) |
|
Structure and Cell Biology |
|
|
554 | (15) |
|
Embryological Derivation of the Reproductive Tract |
|
|
554 | (1) |
|
|
554 | (4) |
|
Physiology and Functional Considerations of the Testis |
|
|
558 | (8) |
|
Structure and Function of the Epididymis and Excurrent Ducts |
|
|
566 | (2) |
|
Structure and Function of Accessory Sex Organs |
|
|
568 | (1) |
|
|
569 | (1) |
|
|
569 | (10) |
|
|
570 | (1) |
|
Cell-specific Toxicity in the Testis |
|
|
571 | (2) |
|
Vascular Effects and Indirect Toxicity to the Testis |
|
|
573 | (2) |
|
Epididymal and Sperm Toxicity |
|
|
575 | (1) |
|
|
576 | (1) |
|
|
576 | (1) |
|
Toxicity to the Developing Reproductive Tract |
|
|
577 | (2) |
|
|
579 | (14) |
|
Disruption of Spermatogenesis |
|
|
580 | (3) |
|
Tubular Dilatation and Tubular Shrinkage |
|
|
583 | (1) |
|
Tubular and Testicular Necrosis |
|
|
583 | (2) |
|
|
585 | (1) |
|
Disruption of Sperm Maturation |
|
|
585 | (1) |
|
|
586 | (1) |
|
Response to Alterations in Hormone Balance |
|
|
586 | (3) |
|
|
589 | (1) |
|
Reproductive Toxicity in Domestic Animals |
|
|
590 | (3) |
|
|
593 | (3) |
|
|
593 | (1) |
|
Characterization of Reproductive Toxicity |
|
|
593 | (2) |
|
Functional Characterization |
|
|
595 | (1) |
|
Testing for Toxicity of the Developing Reproductive Tract |
|
|
596 | (1) |
|
|
596 | (1) |
|
|
597 | (2) |
|
Female Reproductive System |
|
|
599 | (34) |
|
|
599 | (1) |
|
Structure and Functional Physiology |
|
|
600 | (9) |
|
|
600 | (6) |
|
|
606 | (3) |
|
|
609 | (6) |
|
|
609 | (1) |
|
Ovary, Uterus, and Vagina as a Unit |
|
|
609 | (4) |
|
|
613 | (1) |
|
|
613 | (2) |
|
|
615 | (13) |
|
General Responses: Ovary, Uterus, and Vagina as a Unit |
|
|
615 | (5) |
|
|
620 | (2) |
|
Reproductive Toxicity in Domestic Animals |
|
|
622 | (3) |
|
|
625 | (3) |
|
|
628 | (2) |
|
|
628 | (2) |
|
|
630 | (1) |
|
|
630 | (1) |
|
|
630 | (3) |
|
|
633 | (40) |
|
|
633 | (1) |
|
Overview of Fetal Toxicologic Pathology |
|
|
633 | (1) |
|
Basic Principles of Developmental Toxicology |
|
|
634 | |
|
Incidence of Congenital Anomalies |
|
|
534 | (100) |
|
Normal Morphologic Development |
|
|
634 | (4) |
|
Fertilization and Blastocyst Formation |
|
|
635 | (1) |
|
|
635 | (1) |
|
|
635 | (2) |
|
Histogenesis and Functional Maturation |
|
|
637 | (1) |
|
|
638 | (4) |
|
Critical Phases of Intrauterine Development |
|
|
638 | (1) |
|
|
639 | (3) |
|
|
642 | (6) |
|
|
642 | (1) |
|
|
643 | (3) |
|
Intrauterine Growth Retardation |
|
|
646 | (1) |
|
|
646 | (1) |
|
|
647 | (1) |
|
|
647 | (1) |
|
How Dose Relates to Manifestation of Abnormal Development |
|
|
648 | (1) |
|
|
648 | (12) |
|
|
648 | (5) |
|
|
653 | (2) |
|
|
655 | (1) |
|
|
656 | (1) |
|
|
656 | (1) |
|
|
656 | (1) |
|
|
657 | (1) |
|
|
658 | (2) |
|
Developmental Toxicity Testing and Risk Assessment |
|
|
660 | (5) |
|
Hazard Identification and Dose-response Analysis |
|
|
660 | (4) |
|
|
664 | (1) |
|
Field Investigation of Anomalies in Domestic Animals |
|
|
665 | (3) |
|
Defining the Individual Incident |
|
|
665 | (1) |
|
|
666 | (1) |
|
Defining the Maternal Environment |
|
|
666 | (1) |
|
|
667 | (1) |
|
Environmental Analysis: An Epidemiological Approach |
|
|
667 | (1) |
|
|
668 | (1) |
|
|
669 | (4) |
Index |
|
673 | |